CompletedPhase 3NCT01857284
Safety and Efficacy of Tauroursodeoxycholic Acid Versus Ursofalk in the Treatment of Adult Primary Biliary Cirrhosis
Studying Primary biliary cholangitis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Beijing Friendship Hospital
- Principal Investigator
- Dong Ji Jia, DoctorBeijing Friendship Hospital
- Intervention
- Tauroursodeoxycholic Acid Capsules(drug)
- Enrollment
- 216 target
- Eligibility
- 18-70 years · All sexes
- Timeline
- 2009 – 2013
Study locations (25)
- Beijing 302 Hospital, Beijing, Beijing Municipality, China
- Beijing Ditan Hospital, Beijing, Beijing Municipality, China
- Beijing Friendship Hospital, Beijing, Beijing Municipality, China
- Beijing Youan Hospital, Beijing, Beijing Municipality, China
- Chinese PLA General Hospital, Beijing, Beijing Municipality, China
- Peiking University First Hosptial, Beijing, Beijing Municipality, China
- Peking University People's Hospital, Beijing, Beijing Municipality, China
- First Affiliated Hospital,SunYat-Sen University, Guangzhou, Guangdong, China
- Nanfang Hospital of Southern Medical University, Guangzhou, Guangdong, China
- Third Affiliated Hospital,SunYat-Sen University, Guangzhou, Guangdong, China
- Tongji Hospital, Wuhan, Hunan, China
- 85 Military Hospital, Shanghai, Shanghai Municipality, China
- Eastern Hepatobiliary Surgery Hospital, Shanghai, Shanghai Municipality, China
- Huashan Hospital, Shanghai, Shanghai Municipality, China
- NO.3 People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai Municipality, China
- +10 more locations on ClinicalTrials.gov
Collaborators
Beijing Trendful Kangjian Medical Information Consulting Limited Company
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01857284 on ClinicalTrials.govOther trials for Primary biliary cholangitis
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07449793Biochemical Response and Clinical Outcomes in Patients With PBCRenJi Hospital
- RECRUITINGPHASE3NCT07296458FIREFLY Trial: Fenofibrate Intervention---Randomized Evaluation in First-Line PBC TherapyXijing Hospital of Digestive Diseases
- RECRUITINGPHASE3NCT07282353A Study of CS0159 in Patients With PBC With Inadequate Response or Intolerance to UDCACascade Pharmaceuticals, Inc
- RECRUITINGNCT07205874Early Diagnosis of Primary Biliary Cholangitis (PBC) in Patients With Positive Anti-Mitochondrial Antibodies (AMA) and Normal Alkaline Phosphatase (ALP)Hospital Universitario La Paz
- ACTIVE NOT RECRUITINGNCT07049887A Study Describing Scratch and Sleep Patterns in Patients With Primary Biliary Cholangitis (Luminaria)Ipsen
- RECRUITINGNCT07149675PBC Long-term Outcomes StudyBeijing Friendship Hospital
- RECRUITINGEARLY PHASE1NCT07104201Fenofibrate in Subjects With Primary Biliary Cholangitis (PBC)Xijing Hospital of Digestive Diseases
- RECRUITINGNANCT06861465EMPower MechanismsUniversity of Alberta